Karl C. Kuban, MD

Professor, Pediatrics

Karl Kuban
617.414.4521

Biography

Karl Kuban brings depth and breadth in clinical care, research and teaching to his role as Chief of the Pediatric Neurology Division at Boston Medical Center. Dr. Kuban was resident training coordinator in Pediatric Neurology at both Children’s Hospital Boston, where he was on staff for 16 years, and at Tufts-New England Medical Center, where he was Associate Chief for 8 years. He has authored more than 70 original peer-reviewed publications, has created an interactive training CD/video for conducting a pediatric neurological examination, and has received awards for teaching and patient care.

Dr. Kuban completed his pediatrics training at Children’s Hospital Boston and his neurology training in the Longwood Area/Children’s Hospital Neurological Training Program. Dr. Kuban obtained a master’s degree in epidemiology from the Harvard School of Public Health and he has had a broad range of research interests, including ones focused on neonatal neurology, cerebral palsy, childhood stroke, autism and brain injury related to congenital heart disease. He currently serves as co-principal investigator for a multi-center NIH study looking at biological markers in the bloods of babies born under 28 weeks gestation.

Other Positions

  • Director (Section) of Pediatrics>Child Neurology, Child Neurology, Pediatrics, Boston University School of Medicine
  • Professor, VA Boston Healthcare System, Neurology, Boston University School of Medicine

Education

  • University of Miami, MD
  • Ohio State University, BSc
  • Harvard School of Public Health, SM/ScM

Publications

  • Published on 6/4/2021

    Campbell H, Check J, Kuban KCK, Leviton A, Joseph RM, Frazier JA, Douglass LM, Roell K, Allred EN, Fordham LA, Hooper SR, Jara H, Paneth N, Mokrova I, Ru H, Santos HP, Fry RC, O'Shea TM. Neonatal Cranial Ultrasound Findings among Infants Born Extremely Preterm: Associations with Neurodevelopmental Outcomes at 10 Years of Age. J Pediatr. 2021 Jun 04. PMID: 34090894.

    Read at: PubMed
  • Published on 4/16/2021

    Moore PS, Mokrova I, Frazier JA, Joseph RM, Santos HP, Dvir Y, Hooper SR, O'Shea TM, Douglass LM, Kuban KCK. Anxiety and Depression Correlates at Age 10 in Children Born Extremely Preterm. J Pediatr Psychol. 2021 04 16; 46(4):422-432. PMID: 33398339.

    Read at: PubMed
  • Published on 4/6/2021

    Taylor GL, Joseph RM, Kuban KCK, Douglass LM, Laux J, Andrews B, Fry RC, Price WA, O'Shea TM. Changes in Neurodevelopmental Outcomes From Age 2 to 10 Years for Children Born Extremely Preterm. Pediatrics. 2021 May; 147(5). PMID: 33824183.

    Read at: PubMed
  • Published on 3/7/2021

    Venkatesh KK, Leviton A, Fichorova RN, Joseph RM, Douglass LM, Frazier JA, Kuban K, Santos HP, Fry RC, O'Shea TM. Prenatal tobacco smoke exposure and neurological impairment at 10 years of age among children born extremely preterm: a prospective cohort. BJOG. 2021 Mar 07. PMID: 33682301.

    Read at: PubMed
  • Published on 12/11/2020

    Santos HP, Bhattacharya A, Joseph RM, Smeester L, Kuban KCK, Marsit CJ, O'Shea TM, Fry RC. Evidence for the placenta-brain axis: multi-omic kernel aggregation predicts intellectual and social impairment in children born extremely preterm. Mol Autism. 2020 12 11; 11(1):97. PMID: 33308293.

    Read at: PubMed
  • Published on 5/7/2020

    Venkatesh KK, Leviton A, Hecht JL, Joseph RM, Douglass LM, Frazier JA, Daniels JL, Fry RC, O'Shea TM, Kuban KCK. Histologic chorioamnionitis and risk of neurodevelopmental impairment at age 10 years among extremely preterm infants born before 28 weeks of gestation. Am J Obstet Gynecol. 2020 11; 223(5):745.e1-745.e10. PMID: 32387324.

    Read at: PubMed
  • Published on 1/16/2020

    Juul SE, Comstock BA, Wadhawan R, Mayock DE, Courtney SE, Robinson T, Ahmad KA, Bendel-Stenzel E, Baserga M, LaGamma EF, Downey LC, Rao R, Fahim N, Lampland A, Frantz Iii ID, Khan JY, Weiss M, Gilmore MM, Ohls RK, Srinivasan N, Perez JE, McKay V, Vu PT, Lowe J, Kuban K, O'Shea TM, Hartman AL, Heagerty PJ. A Randomized Trial of Erythropoietin for Neuroprotection in Preterm Infants. N Engl J Med. 2020 01 16; 382(3):233-243. PMID: 31940698.

    Read at: PubMed
  • Published on 12/1/2019

    Dvir Y, Frazier JA, Joseph RM, Mokrova I, Moore PS, O'Shea TM, Hooper SR, Santos HP, Kuban K. Psychiatric Symptoms: Prevalence, Co-occurrence, and Functioning Among Extremely Low Gestational Age Newborns at Age 10 Years. J Dev Behav Pediatr. 2019 12; 40(9):725-734. PMID: 31764608.

    Read at: PubMed
  • Published on 10/17/2019

    Tomlinson MS, Santos HP, Stewart JR, Joseph R, Leviton A, Onderdonk AB, Kuban KCK, Heeren T, O'Shea TM, Fry RC. Neurocognitive and social-communicative function of children born very preterm at 10 years of age: Associations with microorganisms recovered from the placenta parenchyma. J Perinatol. 2020 02; 40(2):306-315. PMID: 31624322.

    Read at: PubMed
  • Published on 9/14/2019

    Bangma JT, Kwiatkowski E, Psioda M, Santos HP, Hooper SR, Douglass L, Joseph RM, Frazier JA, Kuban KCK, O'Shea TM, Fry RC. Understanding positive child health. Pediatr Res. 2019 12; 86(6):690-691. PMID: 31521061.

    Read at: PubMed

View 201 more publications: View full profile at BUMC

View all profiles